Literature DB >> 34324772

Youth and parent preferences for an ideal AP system: It is all about reducing burden.

Persis V Commissariat1, Lindsay C Roethke1, Jennifer L Finnegan2, Zijing Guo1, Lisa K Volkening1, Deborah A Butler1, Eyal Dassau1,3, Stuart A Weinzimer2, Lori M Laffel1.   

Abstract

BACKGROUND: As new diabetes technologies improve to better manage glucose levels, users' priorities for future technologies may shift to prioritize burden reduction and ease of use. We used qualitative methods to explore youth and parent desired features of an "ideal" artificial pancreas (AP) system.
METHODS: We conducted semi-structured interviews with 39 youth, ages 10-25 years, and 44 parents. Interviews were audio-recorded, transcribed, and coded using thematic analysis.
RESULTS: Youth (79% female, 82% non-Hispanic white) were (M ± SD) ages 17.0 ± 4.7 years, with diabetes for 9.4 ± 4.9 years, and HbA1c of 8.4 ± 1.1%; 79% were pump-treated and 82% used CGM. Of parents, 91% were mothers and 86% were non-Hispanic white. Participants suggested various ways in which an ideal AP system could reduce physical and emotional burdens of diabetes. Physical burdens could be reduced by lessening user responsibilities to manage glucose for food and exercise, and wear or carry devices. Emotional burden could be reduced by mitigating negative emotional reactions to sound and frequency of alerts, while increasing feelings of normalcy. Youth and parents differed in their suggestions to reduce emotional burden. Participants suggested features that would improve glycemia, but nearly always in the context of how the feature would directly reduce their diabetes-specific burden.
CONCLUSIONS: Although participants expressed interest in improving glucose levels, the pervasive desire among suggested features of an ideal AP system was to minimize the burden of diabetes. Understanding and addressing users' priorities to reduce physical and emotional burden will be necessary to enhance uptake and maintain use of future AP systems.
© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  adolescents; artificial pancreas; automated insulin delivery; burden; children; parents; system design; type 1 diabetes; young adults

Mesh:

Substances:

Year:  2021        PMID: 34324772      PMCID: PMC8530854          DOI: 10.1111/pedi.13252

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  30 in total

1.  General Life and Diabetes-Related Stressors in Early Adolescents With Type 1 Diabetes.

Authors:  Ariana M Chao; Karl E Minges; Chorong Park; Susan Dumser; Kathryn M Murphy; Margaret Grey; Robin Whittemore
Journal:  J Pediatr Health Care       Date:  2015-07-30       Impact factor: 1.812

2.  Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes.

Authors:  Sue A Brown; Boris P Kovatchev; Dan Raghinaru; John W Lum; Bruce A Buckingham; Yogish C Kudva; Lori M Laffel; Carol J Levy; Jordan E Pinsker; R Paul Wadwa; Eyal Dassau; Francis J Doyle; Stacey M Anderson; Mei Mei Church; Vikash Dadlani; Laya Ekhlaspour; Gregory P Forlenza; Elvira Isganaitis; David W Lam; Craig Kollman; Roy W Beck
Journal:  N Engl J Med       Date:  2019-10-16       Impact factor: 91.245

3.  Insulin Pump Use in Children with Type 1 Diabetes: Over a Decade of Disparities.

Authors:  Terri H Lipman; Steven M Willi; C W Lai; Jennifer A Smith; Oona Patil; Colin P Hawkes
Journal:  J Pediatr Nurs       Date:  2020-09-01       Impact factor: 2.145

4.  Best friend or spy: a qualitative meta-synthesis on the impact of continuous glucose monitoring on life with Type 1 diabetes.

Authors:  L H Messer; R Johnson; K A Driscoll; J Jones
Journal:  Diabet Med       Date:  2017-12-27       Impact factor: 4.359

5.  Closing the Loop in Adults, Children and Adolescents With Suboptimally Controlled Type 1 Diabetes Under Free Living Conditions: A Psychosocial Substudy.

Authors:  Katharine D Barnard; Timothy Wysocki; Vanessa Ully; Julia K Mader; Thomas R Pieber; Hood Thabit; Martin Tauschmann; Lalantha Leelarathna; Sara Hartnell; Carlo L Acerini; Malgorzata E Wilinska; Sibylle Dellweg; Carsten Benesch; Sabine Arnolds; Manuel Holzer; Harald Kojzar; Fiona Campbell; James Yong; Jennifer Pichierri; Peter Hindmarsh; Lutz Heinemann; Mark L Evans; Roman Hovorka
Journal:  J Diabetes Sci Technol       Date:  2017-04-03

6.  Automated Insulin Delivery Systems: Hopes and Expectations of Family Members.

Authors:  Kimberly P Garza; Aneta Jedraszko; Lindsey E G Weil; Diana Naranjo; Katharine D Barnard; Lori M B Laffel; Korey K Hood; Jill Weissberg-Benchell
Journal:  Diabetes Technol Ther       Date:  2018-03       Impact factor: 6.118

7.  Realizing a Closed-Loop (Artificial Pancreas) System for the Treatment of Type 1 Diabetes.

Authors:  Rayhan A Lal; Laya Ekhlaspour; Korey Hood; Bruce Buckingham
Journal:  Endocr Rev       Date:  2019-12-01       Impact factor: 19.871

8.  What End Users and Stakeholders Want From Automated Insulin Delivery Systems.

Authors:  Diana Naranjo; Sakinah C Suttiratana; Esti Iturralde; Katharine D Barnard; Jill Weissberg-Benchell; Lori Laffel; Korey K Hood
Journal:  Diabetes Care       Date:  2017-08-25       Impact factor: 19.112

Review 9.  The Do-It-Yourself Artificial Pancreas: A Comprehensive Review.

Authors:  Jothydev Kesavadev; Seshadhri Srinivasan; Banshi Saboo; Meera Krishna B; Gopika Krishnan
Journal:  Diabetes Ther       Date:  2020-04-30       Impact factor: 2.945

10.  One Year Clinical Experience of the First Commercial Hybrid Closed-Loop System.

Authors:  Rayhan A Lal; Marina Basina; David M Maahs; Korey Hood; Bruce Buckingham; Darrell M Wilson
Journal:  Diabetes Care       Date:  2019-09-23       Impact factor: 19.112

View more
  2 in total

Review 1.  Barriers and Facilitators to Diabetes Device Adoption for People with Type 1 Diabetes.

Authors:  Molly L Tanenbaum; Persis V Commissariat
Journal:  Curr Diab Rep       Date:  2022-05-06       Impact factor: 5.430

2.  Significant and persistent improvements in time in range and positive emotions in children and adolescents with type 1 diabetes using a closed-loop control system after attending a virtual educational camp.

Authors:  Ivana Rabbone; Silvia Savastio; Ciro Pigniatiello; Chiara Carducci; Maria Giulia Berioli; Valentino Cherubini; Donatella Lo Presti; Giulio Maltoni; Chiara Mameli; Marco Marigliano; Nicola Minuto; Enza Mozzillo; Elvira Piccinno; Barbara Predieri; Andrea Rigamonti; Carlo Ripoli; Riccardo Schiaffini; Fortunato Lombardo; Davide Tinti; Sonia Toni; Angela Zanfardino; Andrea Enzo Scaramuzza
Journal:  Acta Diabetol       Date:  2022-03-21       Impact factor: 4.087

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.